S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13

Viveve Medical Stock Forecast, Price & News

-0.05 (-3.47%)
(As of 12/3/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
149,736 shs
Average Volume
800,844 shs
Market Capitalization
$14.72 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive VIVE News and Ratings via Email

Sign-up to receive the latest news and ratings for Viveve Medical and its competitors with MarketBeat's FREE daily newsletter.

Viveve Medical logo

About Viveve Medical

Viveve Medical, Inc. engages in the design, development, manufacture, and marketing of platform medical technology. It offers cryogen-cooled monopolar radio frequency technology, which delivered through a radiofrequency generator, hand piece and treatment tip. The Viveve system is a non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company was founded on March 3, 1987 and is headquartered Englewood, CO.


Viveve Medical (NASDAQ:VIVE) Posts Quarterly Earnings Results
November 12, 2021 |  americanbankingnews.com
Viveve Medical's Return On Capital Employed Overview
September 30, 2021 |  benzinga.com
See More Headlines

Industry, Sector and Symbol

Electromedical equipment
Current Symbol
Previous Symbol
Year Founded

Sales & Book Value

Annual Sales
$5.48 million
Book Value
$3.21 per share


Net Income
$-21.92 million
Net Margins
Pretax Margin




Free Float
Market Cap
$14.72 million

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

1.24 out of 5 stars

Medical Sector

1182nd out of 1,390 stocks

Electromedical Equipment Industry

28th out of 30 stocks

Analyst Opinion: 0.0Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Viveve Medical (NASDAQ:VIVE) Frequently Asked Questions

Is Viveve Medical a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Viveve Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Viveve Medical stock.
View analyst ratings for Viveve Medical
or view top-rated stocks.

How has Viveve Medical's stock been impacted by Coronavirus (COVID-19)?

Viveve Medical's stock was trading at $0.84 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, VIVE stock has increased by 65.5% and is now trading at $1.39.
View which stocks have been most impacted by COVID-19

Are investors shorting Viveve Medical?

Viveve Medical saw a drop in short interest in the month of October. As of October 29th, there was short interest totaling 404,000 shares, a drop of 32.9% from the October 14th total of 601,800 shares. Based on an average daily volume of 471,200 shares, the days-to-cover ratio is currently 0.9 days. Approximately 4.0% of the company's shares are short sold.
View Viveve Medical's Short Interest

When is Viveve Medical's next earnings date?

Viveve Medical is scheduled to release its next quarterly earnings announcement on Thursday, February 10th 2022.
View our earnings forecast for Viveve Medical

How were Viveve Medical's earnings last quarter?

Viveve Medical, Inc. (NASDAQ:VIVE) posted its quarterly earnings data on Thursday, November, 11th. The company reported ($0.67) EPS for the quarter, missing analysts' consensus estimates of ($0.58) by $0.09. Viveve Medical had a negative trailing twelve-month return on equity of 108.23% and a negative net margin of 323.58%. During the same quarter last year, the company posted ($2.60) EPS.
View Viveve Medical's earnings history

Who are Viveve Medical's key executives?

Viveve Medical's management team includes the following people:
  • Scott C. Durbin, Chief Executive Officer & Director
  • Marty Kerber, Vice President-Research, Development & Operations
  • Jim B. Robbins, CFO, Chief Accounting Officer & Senior VP-Finance
  • Doug Massey, Vice President-Clinical & Medical Affairs
  • Jeff Sinclair, Vice President-International Sales

What other stocks do shareholders of Viveve Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), HP (HPQ), Fortive (FTV), Lowe's Companies (LOW), SCYNEXIS (SCYX), Western Digital (WDC), Inovio Pharmaceuticals (INO), Viking Therapeutics (VKTX) and Novavax (NVAX).

When did Viveve Medical IPO?

(VIVE) raised $13 million in an initial public offering (IPO) on Tuesday, June 14th 2016. The company issued 1,600,000 shares at $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group acted as the underwriters for the IPO and Maxim Group was co-manager.

What is Viveve Medical's stock symbol?

Viveve Medical trades on the NASDAQ under the ticker symbol "VIVE."

Who are Viveve Medical's major shareholders?

Viveve Medical's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Geode Capital Management LLC (0.49%), Morgan Stanley (0.23%) and Dimensional Fund Advisors LP (0.16%).
View institutional ownership trends for Viveve Medical

Which major investors are buying Viveve Medical stock?

VIVE stock was bought by a variety of institutional investors in the last quarter, including Morgan Stanley, Dimensional Fund Advisors LP, and Geode Capital Management LLC.
View insider buying and selling activity for Viveve Medical
or or view top insider-buying stocks.

How do I buy shares of Viveve Medical?

Shares of VIVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Viveve Medical's stock price today?

One share of VIVE stock can currently be purchased for approximately $1.39.

How much money does Viveve Medical make?

Viveve Medical has a market capitalization of $14.72 million and generates $5.48 million in revenue each year.

How many employees does Viveve Medical have?

Viveve Medical employs 2,018 workers across the globe.

What is Viveve Medical's official website?

The official website for Viveve Medical is www.viveve.com.

Where are Viveve Medical's headquarters?

How can I contact Viveve Medical?

Viveve Medical's mailing address is 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112. The company can be reached via phone at (720) 696-8100, via email at [email protected], or via fax at 720-696-8199.

This page was last updated on 12/4/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.